Dr. Rassouli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 Cumberland Pkwy SE
Atlanta, GA 30339Phone+1 770-431-4186Fax+1 770-431-4186
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2007
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2002 - 2005
Tehran University of Medical Sciences School of MedicineClass of 2000
Certifications & Licensure
GA State Medical License 2006 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- CANVAS - CANagliflozin cardioVascular Assessment Study Start of enrollment: 2009 Dec 09
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Publications & Presentations
PubMed
- 60 citationsStearoyl-Coenzyme A Desaturase 1 Gene Expression Increases after Pioglitazone Treatment and Is Associated with Peroxisomal Proliferator-Activated Receptor-γ Responsive...Aiwei Yao-Borengasser, Negah Rassouli, Vijayalakshmi Varma, Angela M. Bodles, Neda Rasouli
The Journal of Clinical Endocrinology and Metabolism. 2008-11-01 - 655 citationsAdiponectin Expression From Human Adipose Tissue: Relation to Obesity, Insulin Resistance, and Tumor Necrosis Factor-α ExpressionPhilip A. Kern, Gina B. Di Gregorio, Tong Lu, Negah Rassouli, Gouri Ranganathan
Diabetes. 2003-07-01 - 43 citationsA review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.Behzad Molavi, Negah Rassouli, Suveer Bagwe, Neda Rasouli
Vascular Health and Risk Management. 2007-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
